Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Oncol.

Sec. Genitourinary Oncology

Volume 15 - 2025 | doi: 10.3389/fonc.2025.1615012

This article is part of the Research TopicEnhancing Prostate Cancer Diagnosis: Biomarkers and Imaging for Improved Patient OutcomesView all 17 articles

An Interpretable Clinical-Radiomics-Deep Learning Model Based on Magnetic Resonance Imaging for Predicting Postoperative Gleason Grading in Prostate Cancer: A Dual-Center Study

Provisionally accepted
Fuyu  GuoFuyu Guo1Shiwei  SunShiwei Sun2,3Xiaoqian  DengXiaoqian Deng1Yue  WangYue Wang4Wei  YaoWei Yao5Peng  YuePeng Yue6Yangang  ZhangYangang Zhang1,7*Yanbin  LiuYanbin Liu3*Yingzhong  YangYingzhong Yang3*
  • 1Third Hospital of Shanxi Medical College, Taiyuan, China
  • 2Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
  • 3Department of Urology, Taiyuan Central Hospital of Shanxi Medical University, Taiyuan, 030000, China., Taiyuan, Shanxi Province, China
  • 4Department of Urology, Xinzhou People's Hospita, Xinzhou, Shanxi Province, China
  • 5Department of Urology, Datong Fifth People's Hospital, Datong, Shanxi Province, China
  • 6Department of Urology, Handan First Hospital, Handan, Hebei Province, China
  • 7Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, Shanxi Province, China

The final, formatted version of the article will be published soon.

Objective: To develop and test an interpretable machine learning model that combines clinical data, radiomics, and deep learning features using different regions of interest (ROI) from magnetic resonance imaging (MRI) to predict postoperative Gleason grading in prostate cancer (PCa). Methods: A retrospective analysis was conducted on 96 PCa patients from the Third Hospital of Shanxi Medical University (training set) and 33 patients from Taiyuan Central Hospital (testing set) treated between August 2014 and July 2022. Clinical data, including prostate-specific antigen and MRI data, were collected. Tumor and whole-prostate ROIs were delineated on T2-weighted imaging, diffusion-weighted imaging, and apparent diffusion coefficient sequences. Following image preprocessing, traditional radiomics and deep learning features were extracted and combined with clinical features. Various machine learning models were constructed using feature selection methods such as LASSO regression. Model performance was evaluated using receiver operating characteristic (ROC) curves, calibration curves (CALC), decision curve analysis (DCA), and SHapley Additive exPlanations (SHAP) analysis. Results: All combined models performed well in the test set (AUC ≥0.75), with the LightGBM model achieving the highest accuracy (0.848). SHAP analysis effectively illustrated the contribution of each feature. The CALC demonstrated good agreement between predicted probabilities and actual outcomes, and DCA further indicated that the models provided significant net benefits for clinical decision-making across various risk thresholds. Conclusion: This study developed and validated interpretable MRI-based machine learning models that combine clinical data with radiomics and deep learning features from different regions of interest, demonstrating good performance in predicting postoperative Gleason grading in PCa.

Keywords: MRI, Shap, Radiomics, deep learning, machine learning, prostate cancer, Gleason grading

Received: 20 Apr 2025; Accepted: 26 Aug 2025.

Copyright: © 2025 Guo, Sun, Deng, Wang, Yao, Yue, Zhang, Liu and Yang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Yangang Zhang, Third Hospital of Shanxi Medical College, Taiyuan, China
Yanbin Liu, Department of Urology, Taiyuan Central Hospital of Shanxi Medical University, Taiyuan, 030000, China., Taiyuan, Shanxi Province, China
Yingzhong Yang, Department of Urology, Taiyuan Central Hospital of Shanxi Medical University, Taiyuan, 030000, China., Taiyuan, Shanxi Province, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.